If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
2
Followers on Owler
Fosun Kate is a China-based biotechnology company that develops and commercializes tumor cell therapy products for patients...
Read more
Overview
Competitors
Funding
News & Insights
Fosun Kate is a China-based biotechnology company that develops and commercializes tumor cell therapy products for patients...
Read more
CEO
Richard Wang
CEO Approval Rating
80/100
Weigh In
2017
Shanghai
Shanghai Municipality
Private
Pharmaceuticals & Biotechnology
Biotechnology
2834
NAICS listing
http://www.fosunkitebio.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
100-250
Agree?
Yes
No
Funding
$20M
News
Latest News
Jan 12, 2024
Yicai Global
Fosun Kite: Fosun Kite's CAR-T Cell Therapy Is China's First Innovative Biological Drug Patients Pay Based on Efficacy
Jul 19, 2023
ChinaBio Today
Fosun Kite: Fosun Kite Approved to Launch CAR-T as Second Line Therapy for B-Cell Lymphoma
Oct 27, 2022
PR Newswire Asia
Press Release: Fosun Kite : NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review
Jun 24, 2021
Yicai Global
Fosun Kite: China Approves First CAR T-Cell Therapy for Lymphoma
Mar 18, 2020
firstwordpharma
Fosun Kite: Fosun Kite's Axicabtagene Ciloleucel Granted Priority Review by China NMPA
Follow and Get Alerts
Fosun Kite Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 12 + competitors
Trending Companies